Remus Pharmaceuticals IPO is to open on May 17. The company is to raise ā¹47.69 crores via IPO. Remus Pharmaceuticals Limited is marketing, distributes, and exporting finished formulations of pharmaceutical drugs. The company is backed by expert scientists. The company deals in API and provides technical consultancy services. The company reported revenue of ā¹25.44 crores in 2022 against revenues of ā¹19.22 crores in 2021. The IPO price band is fixed at ā¹1150 to ā¹1229 Per Equity Share. The Remus Pharmaceuticals IPO to list on NSE.
What is Remus Pharmaceuticals IPO GMP Today?
The Remus Pharmaceuticals IPO GMP aka Grey Market Premium is ā¹600.
What is Remus Pharmaceuticals IPO Kostak Rates Today?
The Remus Pharmaceuticals IPO Kostak Rate is ā¹-.
What is Remus Pharmaceuticals IPO Subject to Sauda Price Today?
The Remus Pharmaceuticals IPO subject to sauda rates is ā¹55000.
Remus Pharmaceuticals IPO Expected Returns?
The Remus Pharmaceuticals expected return is 49%.
Remus Pharmaceuticals IPO GMP Live Rates day by day with Kotak rates.
| Date | GMP | Kostak | Subject to |
| Today | ā¹600 | ā¹- | ā¹55000 |
| 25 May | ā¹400 | ā¹- | ā¹35000 |
| 24 May | ā¹400 | ā¹- | ā¹35000 |
| 23 May | ā¹350 | ā¹- | ā¹35000 |
| 22 May | ā¹80 | ā¹- | ā¹10000 |
| 19 May | ā¹50 | ā¹- | ā¹6000 |
| 18 May | ā¹70 | ā¹- | ā¹6000 |
| 17 May | ā¹70 | ā¹- | ā¹6000 |
| 16 May | ā¹100 | ā¹- | ā¹7000 |
| 15 May | ā¹100 | ā¹- | ā¹7000 |
| 13 May | ā¹150 | ā¹- | ā¹7000 |
| 12 May | ā¹125 | ā¹600 | ā¹6000 |
| 11 May | ā¹125 | ā¹600 | ā¹6000 |
| 10 May | ā¹- | ā¹- | ā¹- |
| 9 May | ā¹- | ā¹- | ā¹- |
Remus Pharmaceuticals IPO GMP aka Grey Market Premium FAQs:
What is Remus Pharmaceuticals IPO GMP Today?
Remus Pharmaceuticals IPO GMP is ā¹600 as of today.
What is Remus Pharmaceuticals IPO Kostak Rate Today?
Remus Pharmaceuticals IPO Kostak Rate is ā¹- as of today.
What is Remus Pharmaceuticals IPO Subject to Sauda Today?
Remus Pharmaceuticals IPO Subject to Sauda is ā¹55000 as of today.
What is Remus Pharmaceuticals IPO Expected Returns?
Remus Pharmaceuticals IPO Expected Returns is 49%.
Disclaimer:
- IPO Grey Market Premium (Remus Pharmaceuticals IPO GMP) mention is valid for the specific date as mentioned in the header.
- We are not buying and selling IPO forms on IPO Grey Market.
- Kostak Rate is the premium one gets by selling his/her IPO application (in an off-market transaction) to someone else even before allotment or listing of the issue.
- Do not subscribe for IPO by just seeing the premium Price as it may change anytime before listing. Subscribe only considering the fundamentals of the companies.
Follow IPO Watch for the upcoming IPO news and their reviews, also keep following us on Twitter, Facebook, and Instagram. For our latest videos, subscribe to our YouTube channel.
